上海交通大学学报（医学版）

上海交通大学学报（医学版） >

2025 , Vol. 45 >Issue 2: 247 - 252

DOI: https://doi.org/10.3969/j.issn.1674-8115.2025.02.015

综述

精神障碍患者视网膜结构变化的研究进展

  • 王偲佳 ,
  • 魏燕燕 ,
  • 钱禛颖 ,
  • 李清伟 ,
  • 王继军
展开
  • 1.上海交通大学医学院附属精神卫生中心脑电影像眼动研究室，上海 200030
    2.上海市宝山区精神卫生中心精神科，上海 201906
    3.同济大学附属同济医院精神医学科，上海 200065
王偲佳（1997—），女，硕士生；电子信箱：wangsi_jia@outlook.com。
王继军，主任医师，博士；电子信箱：jijunwang27@163.com
李清伟，主任医师，博士；电子信箱：lianocd@tongji.edu.cn。

收稿日期: 2024-06-04

  录用日期: 2024-11-04

  网络出版日期: 2025-02-28

基金资助

上海交通大学医学院附属精神卫生中心院级课题(2022-YJ09)

收起

Research progress in retinal structural alterations in patients with mental disorders

  • WANG Sijia ,
  • WEI Yanyan ,
  • QIAN Zhenying ,
  • LI Qingwei ,
  • WANG Jijun
Expand
  • 1.Department of Electroencephalography and Imaging, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China
    2.Department of Psychiatry, Baoshan District Mental Health Center, Shanghai 201906, China
    3.Department of Psychiatry, Tongji Hospital of Tongji University, Shanghai 200065, China
WANG Jijun, E-mail: jijunwang27@163.com
LI Qingwei, E-mail: lianocd@tongji.edu.cn.

Received date: 2024-06-04

  Accepted date: 2024-11-04

  Online published: 2025-02-28

Supported by

Project of Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine(2022-YJ09)

Fold

摘要

精神障碍常与其他躯体疾病共病，已成为全球患者致残的主要原因之一。早期诊断和治疗对于精神障碍的管理至关重要。目前，精神障碍生物标志物的研究主要集中在基因、血液指标和脑部影像；此外，一些客观的表型标志物也逐渐成为研究的热点。视网膜是中枢神经系统的一部分，由间脑延伸而来，在胚胎发育期间与大脑共同发育。鉴于神经退行性疾病和精神障碍在病理生理学中的重叠机制，研究视网膜内各层组织的结构和功能变化，已成为精神障碍研究的新方向。随着光学相干断层扫描（optical coherence tomography，OCT）技术的发展，研究人员能够无创、非接触地对视网膜结构进行显微成像，精确量化各视网膜亚层的厚度。已有研究利用OCT探索精神分裂症、双相情感障碍、抑郁症等精神疾病患者的视网膜结构变化，但目前缺乏系统的总结与归纳。将目前已有精神障碍患者视网膜结构变化的研究结果及进展进行总结，发现部分精神障碍患者的视网膜亚层厚度显著减小。这些发现提示视网膜结构有潜力成为精神障碍的生物标志物，为精神障碍的诊断和治疗提供新的研究思路。

关键词： 光学相干断层扫描; 精神障碍; 精神分裂症; 情感障碍; 视网膜神经纤维层; 视网膜

本文引用格式

王偲佳 , 魏燕燕 , 钱禛颖 , 李清伟 , 王继军 . 精神障碍患者视网膜结构变化的研究进展[J]. 上海交通大学学报（医学版）, 2025 , 45(2) : 247 -252 . DOI: 10.3969/j.issn.1674-8115.2025.02.015

Abstract

Mental disorders frequently co-occur with other physical illnesses, becoming one of the leading causes of disability worldwide. Early diagnosis and intervention are crucial for the effective management of these disorders. Currently, biomarker studies on mental disorders predominantly concentrate on genes, blood indicators, and imaging features of the brain. There is a growing interest in objective phenotypic markers as a research focus. It is established that the retina is part of the central nervous system (CNS), which extends from the mesencephalon and develops concurrently with the brain during the embryonic period. Given the overlapping pathophysiological mechanisms between neurodegenerative diseases and mental disorders, studying the structural and functional changes in the inner layers of the retina has emerged as a new direction in mental health research. The advent of optical coherence tomography (OCT) has enabled microscopic imaging of retinal structures. OCT is capable of objectively quantifying the retinal sub-layers and offers the advantages of being non-invasive, non-contact, and high-resolution. The use of OCT to explore structural changes in the retina among individuals with schizophrenia, bipolar disorder, major depression and other psychiatric disorders has been well documented; however, there is a paucity of reviews on this topic. This review summarizes current research on retinal structural alterations in patients with mental disorders, and the results demonstrate reduced thickness in certain sub-layers of the retina structure in patients with several mental disorders, which supports that the retina structure has the potential to be a biomarker for mental disorders and offers a novel avenue for research in the diagnosis and treatment.

Key words： optical coherence tomography (OCT); mental disorder; schizophrenia; mood disorder; retinal nerve fiber layer (RNFL); retina

参考文献

1 GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990?2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet Psychiatry, 2022, 9(2): 137-150.
2 CLARK L A, CUTHBERT B, LEWIS-FERNáNDEZ R, et al. Three approaches to understanding and classifying mental disorder: ICD-11, DSM-5, and the national institute of mental health's research domain criteria (RDoC)[J]. Psychol Sci Public Interest, 2017, 18(2): 72-145.
3 THOMPSON S M. Modulators of GABAA receptor-mediated inhibition in the treatment of neuropsychiatric disorders: past, present, and future[J]. Neuropsychopharmacology, 2024, 49(1): 83-95.
4 LONDON A, BENHAR I, SCHWARTZ M. The retina as a window to the brain-from eye research to CNS disorders[J]. Nat Rev Neurol, 2013, 9(1): 44-53.
5 MAUSCHITZ M M, LOHNER V, KOCH A, et al. Retinal layer assessments as potential biomarkers for brain atrophy in the Rhineland Study[J]. Sci Rep, 2022, 12(1): 2757.
6 LIM J K L, LI Q X, HE Z, et al. Retinal functional and structural changes in the 5×FAD mouse model of Alzheimer's disease[J]. Front Neurosci, 2020, 14: 862.
7 GAIRE B P, KORONYO Y, FUCHS D T, et al. Alzheimer's disease pathophysiology in the retina[J]. Prog Retin Eye Res, 2024, 101: 101273.
8 CHEUNG C Y, MOK V, FOSTER P J, et al. Retinal imaging in Alzheimer's disease[J]. J Neurol Neurosurg Psychiatry, 2021, 92(9): 983-994.
9 GEEVARGHESE A, WOLLSTEIN G, ISHIKAWA H, et al. Optical coherence tomography and glaucoma[J]. Annu Rev Vis Sci, 2021, 7: 693-726.
10 OKUGAWA G, SEDVALL G C, AGARTZ I. Reduced grey and white matter volumes in the temporal lobe of male patients with chronic schizophrenia[J]. Eur Arch Psychiatry Clin Neurosci, 2002, 252(3): 120-123.
11 ASCASO F J, LAURA C, QUINTANILLA M á, et al. Retinal nerve fiber layer thickness measured by optical coherence tomography in patients with schizophrenia: a short report[J]. Eur J Psychiat, 2010, 24(4): 227-235.
12 LEE W W, TAJUNISAH I, SHARMILLA K, et al. Retinal nerve fiber layer structure abnormalities in schizophrenia and its relationship to disease state: evidence from optical coherence tomography[J]. Invest Ophthalmol Vis Sci, 2013, 54(12): 7785-7792.
13 YILMAZ U, Kü?üK E, üLGEN A, et al. Retinal nerve fiber layer and macular thickness measurement in patients with schizophrenia[J]. Eur J Ophthalmol, 2016, 26(4): 375-378.
14 BOUDRIOT E, SCHWORM B, SLAPAKOVA L, et al. Optical coherence tomography reveals retinal thinning in schizophrenia spectrum disorders[J]. Eur Arch Psychiatry Clin Neurosci, 2023, 273(3): 575-588.
15 徐淑莉, 禚传君, 陈清刚. 精神分裂症患者黄斑及视神经纤维损害研究[J]. 精神医学杂志, 2023, 36(6): 638-641.
  XU S L, ZHUO C J, CHEN Q G. Research on the lesions of macula and optic nerve fibers in patients with schizophrenia[J]. Journal of Psychiatry, 2023, 36(6): 638-641.
16 SILVERSTEIN S M, PATERNO D, CHERNESKI L, et al. Optical coherence tomography indices of structural retinal pathology in schizophrenia[J]. Psychol Med, 2018, 48(12): 2023-2033.
17 JEROTIC S, RISTIC I, PEJOVIC S, et al. Retinal structural abnormalities in young adults with psychosis spectrum disorders[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2020, 98: 109825.
18 MILLER M, ZEMON V, NOLAN-KENNEY R, et al. Optical coherence tomography of the retina in schizophrenia: inter-device agreement and relations with perceptual function[J]. Schizophr Res, 2020, 219: 13-18.
19 KANGO A, GROVER S, GUPTA V, et al. A comparative study of retinal layer changes among patients with schizophrenia and healthy controls[J]. Acta Neuropsychiatr, 2023, 35(3): 165-176.
20 ASCASO F J, RODRIGUEZ-JIMENEZ R, CABEZóN L, et al. Retinal nerve fiber layer and macular thickness in patients with schizophrenia: influence of recent illness episodes[J]. Psychiatry Res, 2015, 229(1/2): 230-236.
21 SAIDHA S, SOTIRCHOS E S, OH J, et al. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis[J]. JAMA Neurol, 2013, 70(1): 34-43.
22 DINKIN M. Trans-synaptic retrograde degeneration in the human visual system: slow, silent, and real[J]. Curr Neurol Neurosci Rep, 2017, 17(2): 16.
23 TüRK?ZER H B, LIZANO P, ADHAN I, et al. Regional and sex-specific alterations in the visual cortex of individuals with psychosis spectrum disorders[J]. Biol Psychiatry, 2022, 92(5): 396-406.
24 SEKAR A, BIALAS A R, DE RIVERA H, et al. Schizophrenia risk from complex variation of complement component 4[J]. Nature, 2016, 530(7589): 177-183.
25 KURTULMUS A, ELBAY A, PARLAKKAYA F B, et al. An investigation of retinal layer thicknesses in unaffected first-degree relatives of schizophrenia patients[J]. Schizophr Res, 2020, 218: 255-261.
26 KAYA H, AYIK B, TASDELEN R, et al. Comparing retinal changes measured by optical coherence tomography in patients with schizophrenia and their siblings with healthy controls: are retinal findings potential endophenotype candidates?[J]. Asian J Psychiatr, 2022, 72: 103089.
27 KOMATSU H, ONOGUCHI G, SILVERSTEIN S M, et al. Retina as a potential biomarker in schizophrenia spectrum disorders: a systematic review and meta-analysis of optical coherence tomography and electroretinography[J]. Mol Psychiatry, 2024, 29(2): 464-482.
28 MEHRABAN A, SAMIMI S M, ENTEZARI M, et al. Peripapillary retinal nerve fiber layer thickness in bipolar disorder[J]. Graefes Arch Clin Exp Ophthalmol, 2016, 254(2): 365-371.
29 MUSTAFA A, TURGAY U. Optical coherence tomography angiography in patients with euthymic bipolar disorder[J]. J Affect Disord, 2022, 317: 15-21.
30 KALENDEROGLU A, SEVGI-KARADAG A, CELIK M, et al. Can the retinal ganglion cell layer (GCL) volume be a new marker to detect neurodegeneration in bipolar disorder?[J]. Compr Psychiatry, 2016, 67: 66-72.
31 KHALIL M A, SALEH A A, GOHAR S M, et al. Optical coherence tomography findings in patients with bipolar disorder[J]. J Affect Disord, 2017, 218: 115-122.
32 POLO V, SATUE M, GAVIN A, et al. Ability of swept source OCT to detect retinal changes in patients with bipolar disorder[J]. Eye, 2019, 33(4): 549-556.
33 GOKCINAR N B, BUTURAK S V, OZKAL F, et al. Optical coherence tomography neurodegenerative findings in patients with bipolar disorder[J]. Asia Pac Psychiatry, 2020, 12(4): e12394.
34 AYIK B, KAYA H, TASDELEN R, et al. Retinal changes in bipolar disorder as an endophenotype candidate: comparison of OCT-detected retinal changes in patients, siblings, and healthy controls[J]. Psychiatry Res, 2022, 313: 114606.
35 KURT A, ZOR K R, Y?LD?R?M BI?ER G, et al. Optical coherence tomography findings in bipolar disorder patients and the related factors[J]. Psychiatry Clin Psychopharmacol, 2023, 33(4): 254-263.
36 ALTUN I K, TUREDI N, ARAS N, et al. Psychopharmacological signatures in the retina in schizophrenia and bipolar disorder: an optic coherence tomography study[J]. Psychiatr Danub, 2020, 32(3/4): 351-358.
37 PRASANNAKUMAR A, KUMAR V, MAILANKODY P, et al. A systematic review and meta-analysis of optical coherence tomography studies in schizophrenia, bipolar disorder and major depressive disorder[J]. World J Biol Psychiatry, 2023, 24(8): 707-720.
38 JUNG K I, HONG S Y, SHIN D Y, et al. Attenuated visual function in patients with major depressive disorder[J]. J Clin Med, 2020, 9(6): 1951.
39 LIU Y H, TONG Y S, HUANG L Z, et al. Factors related to retinal nerve fiber layer thickness in bipolar disorder patients and major depression patients[J]. BMC Psychiatry, 2021, 21(1): 301.
40 LIU X, LAI S K, MA S S, et al. Development of a novel retina-based diagnostic score for early detection of major depressive disorder: an interdisciplinary view[J]. Front Psychiatry, 2022, 13: 897759.
41 YILDIZ M, ALIM S, BATMAZ S, et al. Duration of the depressive episode is correlated with ganglion cell inner plexifrom layer and nasal retinal fiber layer thicknesses: optical coherence tomography findings in major depression[J]. Psychiatry Res Neuroimaging, 2016, 251: 60-66.
42 S?NMEZ ?, K??GER F, AYKAN ü. Retinal nerve fiber layer thickness measurement by spectral-domain optical coherence tomography in patients with major depressive disorder[J]. Noro Psikiyatr Ars, 2017, 54(1): 62-66.
43 SCH?NFELDT-LECUONA C, SCHMIDT A, KREGEL T, et al. Retinal changes in patients with major depressive disorder: a controlled optical coherence tomography study[J]. J Affect Disord, 2018, 227: 665-671.
44 GENC A, DALKIRAN M, PIRDO?AN AYD?N E, et al. The alteration of retinal nerve fibre layer thickness with repetitive transcranial magnetic stimulation in patients with treatment resistant major depression[J]. Int J Psychiatry Clin Pract, 2019, 23(1): 57-61.
45 KALENDEROGLU A, ?ELIK M, SEVGI-KARADAG A, et al. Optic coherence tomography shows inflammation and degeneration in major depressive disorder patients correlated with disease severity[J]. J Affect Disord, 2016, 204: 159-165.
46 van der HEIDE F C T, STEENS I L M, GERAETS A F J, et al. Association of retinal nerve fiber layer thickness, an index of neurodegeneration, with depressive symptoms over time[J]. JAMA Netw Open, 2021, 4(11): e2134753.
47 POLAT S, GEDIZ B S, ERCAN A C, et al. The place of optical coherence tomography in patients with obsessive compulsive disorder[J]. Eurasian J Med, 2019, 51(3): 237-241.
48 BAYKARA S, KAZ?AN A, YILDIRIM H, et al. Retinal changes in generalized anxiety disorder patients[J]. Int J Psychiatry Med, 2024, 59(3): 270-286.
49 BAYKARA S, YILDIRIM H, KAZ?AN A, et al. Retinal changes in panic disorder patients[J]. Psychiatry Res Neuroimaging, 2022, 324: 111496.
Options
文章导航

/

〈 〉